Integra LifeSciences (Nasdaq: IART) has completed its previously announced $1.045 billion purchase of Johnson & Johnson’s Codman Neurosurgery business, the companies announced today. “The addition of Codman Neurosurgery expands our global leadership position by creating one of the broadest medical device portfolios in the neurosurgery market,” Peter Arduini, Integra’s president and CEO, said in a […]
Integra LifeSciences deals $48m in neurosurgery assets to Natus Medical
Integra LifeSciences (NSDQ:IART) said today that it plans to deal some of its neurosurgery assets to Natus Medical (NSDQ:BABY) for nearly $48 million, contingent on the consummation of its $1 billion buyout of the Codman Neurosurgery business from Johnson & Johnson (NYSE:JNJ). Plainsboro, N.J.-based Integra said the sale to Natus includes its line of Camino intracranial […]
Johnson & Johnson rolls Pulsar Vascular, Neuravi into new Cerenovus neurovascular biz
Updated to clarify that J&J’s existing Codman Neuro neurovascular portfolio will also be included in the new Cerenovus business. Johnson & Johnson (NYSE:JNJ) said yesterday that it’s medical device division is rolling the Pulsar Vascular and Neuravi acquisitions, as well as its existing Codman Neuro neurological portfolio, into a new neurovascular business dubbed Cerenovus. The […]
Medtech M&A: The 10 biggest deals so far in 2017
Over the past several years, the healthcare industry as a whole has experienced an abundance of mergers and acquisitions – major players are buying up their peers in deals ranging from millions to billions. The trend is continuing, and the healthcare playing field continues to be shaped by these mega-transactions. For the medical device industry, […]
Integra LifeSciences, Johnson & Johnson pass papers on $1B Codman Neuro buy
Integra LifeSciences (NSDQ:IART) said yesterday that it passed papers with Johnson & Johnson (NYSE:JNJ) last week on its $1.05 billion cash bid for J&J’s Codman Neurosurgery unit. Completing the deal still hinges on the expiration of the Hart-Scott-Rodino waiting period and antitrust approvals in Spain and the U.K., Integra said in a regulatory filing. When it announced the deal […]
Codman Neuro acquires Neuravi
Johnson & Johnson (NYSE:JNJ) business unit Codman Neuro said today it acquired Neuravi and its portfolio of neurovascular therapy technology for an undisclosed amount. Neuravi produces the EmboTrap and EmboTrap II revascularization platforms designed capture clots and allow blood flow to resume immediately after the clot has been secured in patients who have experienced a stroke. J&J’s Codman Neuro […]
Integra LifeSciences bids $1B for Johnson & Johnson’s Codman Neurosurgery biz
Integra LifeSciences (NSDQ:IART) said today that it’s floating a $1.05 billion cash offer for Johnson & Johnson (NYSE:JNJ) unit Codman Neurosurgery. Plainsboro, N.J.-based Integra said it plans to finance the buyout with cash on hand, a credit revolver and a new term loan; BofA Merrill Lynch and JPMorgan are backing the deal, the company said. […]
J&J’s Codman Neuro picks up Pulsar Vascular
Johnson & Johnson‘s (NYSE:JNJ) Codman Neuro said last week it picked up Pulsar Vascular, which produces the PulseRider device for treating brain aneurysms, for an undisclosed amount. The PulseRider is designed to shore up the blood vessels around wide-necked aneurysms at or near a bifurcation of the basilar tip or carotid terminus and facilitate the implantation of […]
J&J’s Codman Neuro inks distro deal with InNeuroCo
Johnson & Johnson‘s (NYSE:JNJ) Codman Neuro said last week it inked an exclusive U.S. and European distribution deal with InNeuroCo for its intermediate catheters designed for the minimally invasive treatment of hemorrhagic stroke. Codman Neuro made the announcement at the Society of NeuroInterventional Surgery’s 13th annual meeting, Codman Neuro said. “Intermediate catheters are increasingly used by neurovascular specialists […]
J&J’s Codman Neuro launches aneurysm coils
Johnson & Johnson‘s (NYSE:JNJ) Codman Neuro said yesterday it launched a new platform of embolic coils for the treatment of brain aneurysms. The announcement was made at the Society of NeuroInterventional Surgery’s annual meeting. The new platform of coils come with enhanced detachment systems that Codman Neuro said improve microcatheter stability. The coil’s delivery wires […]
Press Release: REVIVE SE thrombectomy device approved for ischemic stroke patients in China, South Korea and Taiwan
MassDevice Network
@MassDevice
LinkedIn
Google+